Investors / stance tracking
What David Mandelbaum is saying
Portfolio Manager, OnePoint BFG
8 dated public stances tracked since 2025-01-18, most recently 2025-08-15. Each line carries the date and the venue it came from; quotation marks mean verbatim. Methodology.
The stances below are c8alpha's editorial distillation of David Mandelbaum's public commentary — television, podcasts, and interviews — compiled by automated transcript analysis and dated to the episode they came from. They may lag the speaker's current view and may contain extraction errors. Text in quotation marks is verbatim from the episode; everything else is our paraphrase. David Mandelbaum is not affiliated with c8alpha and has not endorsed this page. Nothing here is investment advice.
Think we got something wrong? Report a misattribution — we correct it or take it down.
8
tracked stances
6
themes
0
side flips
2025-08-15
last heard
Raw direction-aware returns on public statements — long calls credited when the price rose, shorts when it fell, shorts capped at −100% — in a rising market this mostly measures who was long, not who has skill. Returns run from the stance date; calls are rarely closed publicly, so fixed 90-day / 180-day / 1-year horizons are used. A horizon shows only once it has fully matured, and only at 5+ scored stances.
Most-argued themes
| Theme | Stances | Lean | Mix | Last |
|---|---|---|---|---|
| HEALTHCARE SECTOR | 3 | 3 bullish | 2025-08-15 | |
| BSX | 1 | 1 bullish | 2025-01-18 | |
| MANAGED CARE / HMOS | 1 | 1 bearish | 2025-01-18 | |
| MEDICAL TECHNOLOGY (MEDTECH) | 1 | 1 bullish | 2025-08-15 | |
| NIH | 1 | 1 bearish | 2025-03-08 | |
| PHARMA STOCKS | 1 | 1 bullish | 2025-07-11 |
Tracked stances
bullish / bearish is a view they argued; owns / short is a position they said they hold.
2025-08-15
HEALTHCARE SECTOR
bullish
Wealthion · video
Healthcare has underperformed the S&P by 30% over 52 weeks and reached historically low relative valuations due to three converging headwinds — sector rotation into AI, high-profile single-stock selloffs in UNH and LLY, and policy overhangs — all of which are…
“healthcare has underperformed the S&P by 30% over the past 52 weeks...trading at historic low valuations relative to the market”
Finding Bargains In An Overvalued Market | Rise UP!
2025-08-15
MEDICAL TECHNOLOGY (MEDTECH)
bullish
Wealthion · video
MedTech companies generating volume-driven double-digit organic growth in large addressable markets have been indiscriminately sold off in the broad healthcare drawdown despite tariff exposure that can be navigated and isolated
“companies generating volume-driven double-digit organic growth...that have gotten caught up more recently in the broad-based selloff”
Finding Bargains In An Overvalued Market | Rise UP!
2025-07-11
PHARMA STOCKS
bullish
Wealthion · video
Pharma stock prices are already discounting worst-case tariff outcomes and most-favored-nation pricing scenarios that are unlikely to materialize, creating a valuation cushion—especially given the 12–18 month implementation delay
“stock prices are discounting worst case tariff outcomes... unlikely to manifest in reality”
Hot Markets Call for a Cool-Headed Approach | Rise UP!
2025-03-08
NIH
bearish
Wealthion · video
Companies with high NIH funding dependence face direct revenue risk as government cuts to academic research imperil that funding stream
“companies that have high exposure to NIH funding which is now somewhat imperiled given the cuts”
Rise Up Special Report: Market Mayhem, Tariffs & Recession Talk
2025-03-08
HEALTHCARE SECTOR
bullish
Wealthion · video
Healthcare earnings are accelerating to mid-to-high teens growth while the Magnificent 7 decelerates, and policy risks from Doge/Medicaid are manageable for companies with secular growth and inelastic demand
“conditions are in place for that outperformance to continue”
Rise Up Special Report: Market Mayhem, Tariffs & Recession Talk
2025-01-18
HEALTHCARE SECTOR
bullish
Wealthion · video
Healthcare underperformed by the largest magnitude in three decades due to market structure rotation into mega-cap tech and elevated policy-risk perception, but at a 20% discount to market multiples with improving fundamentals and expected policy-risk…
“the opportunity set should be much better going forward we expect than it has been in 2024”
This Week’s Must-Know Market News | ft. David Mandelbaum | Rise UP!
2025-01-18
MANAGED CARE / HMOS
bearish
Wealthion · video
Health insurers face a double headwind of elevated medical loss ratios from rising utilization and maximum policy-risk exposure from the new administration, making better opportunities available elsewhere in healthcare
This Week’s Must-Know Market News | ft. David Mandelbaum | Rise UP!
2025-01-18
BSX
bullish
Wealthion · video
Medical technology companies like Boston Scientific are among his two most exciting opportunities because they carry minimal exposure to healthcare policy risk even in a worst-case regulatory scenario
“the two areas that I would find most exciting for us are the areas that are least exposed to policy risk”
90d -7.3% · 180d +3.7% · 1y -9.6%
This Week’s Must-Know Market News | ft. David Mandelbaum | Rise UP!
Idea Scout Weekly
Every Sunday: who said what across the tape we track — 845 voices, 2,419 episodes and articles — with side-flips and points of disagreement called out. Free. How we track it.
Free · double opt-in · unsubscribe in one click